regulatory_compliance

Schwarz Digits Launches First European RISE with SAP Hyperscaler

Image
Schwarz Digits Launches First European RISE with SAP Hyperscaler

Bad Friedrichshall – September 10, 2026 -- Schwarz Digits and SAP have launched RISE with SAP on STACKIT, making STACKIT the only European hyperscaler certified to run SAP's flagship cloud ERP program, with commercial availability starting immediately and technical provisioning set for November 2026.

Certification took 18 months to complete

Schwarz Digits achieved SAP certification for STACKIT within one and a half years, according to Chief Sales Officer Bernd Wagner. He said the milestone removes 'the last hurdle' for on-premises customers considering a cloud migration, positioning STACKIT as the first European hyperscaler to combine sovereignty with competitive pricing.

Utemuratov Foundation Puts $1M Into Almaty Gas Network Expansion

Image
Utemuratov Foundation Puts $1M Into Almaty Gas Network Expansion

Almaty – September 10, 2026 -- The Bulat Utemuratov Foundation has allocated 460 million tenge (approximately US$1 million) to fund the gasification of private residential homes in Almaty, partnering with the city's Akimat (Mayor's Office) on the project.

Foundation funding targets coal-to-gas conversion for private homes

Under a newly signed memorandum, the Almaty City Akimat will inspect private residences, consult with residents on connection procedures and coordinate the transition to natural gas heating. Qualified contractors will then carry out the construction and installation work required to connect each home to the gas network.

IVA Blasts PAN Study Claiming 400 Million Pesticide Poisonings

Frankfurt – September 10, 2026 -- The German agricultural industry association IVA has dismissed a new study by the Pesticide Action Network (PAN) claiming more than 400 million pesticide-related poisoning cases occur globally each year, calling the figure scientifically indefensible.

IVA says PAN conflates exposure with confirmed poisoning

The Industrieverband Agrar e.V. (IVA) argues the PAN study fails to define what qualifies as a poisoning, relying heavily on self-reported symptoms rather than medically confirmed diagnoses. According to IVA, this methodological gap means exposure and actual poisoning are not properly separated, inflating the headline figure. A previous PAN study on global poisoning cases was withdrawn after similar criticism of its methodology and data sources.

94% of German Firms Show Deep Tech Dependencies, Capgemini Finds

Berlin – September 10, 2026 -- Ninety-three percent of organizations worldwide now discuss digital sovereignty at board level, yet 59% consider full technological independence an unrealistic goal, according to a new Capgemini Research Institute report based on a survey of 1,300 business and technology executives conducted in April 2026.

The report, titled "Digital Sovereignty: From Policy Ambition to Executive Imperative," finds that two-thirds of organizations globally define digital sovereignty as "resilient interdependence" rather than complete self-sufficiency, favoring targeted control over critical technologies and strategic partnerships instead.

Hang Feng H1 2026 Revenue Drops 73% as Firm Pivots to RWA, Wins New License

Hong Kong – September 10, 2026 -- Hang Feng Technology Innovation Co., Ltd., a Nasdaq-listed company headquartered in Hong Kong, reported a 73% year-on-year revenue decline for the six months ended June 30, 2026, as it redirects resources away from its legacy consulting business toward real-world asset (RWA) initiatives.

Revenue falls to $362,511 as consulting business contracts

Total revenue for the reporting period was $362,511, down from $1,327,707 in the first half of 2025. The company swung to a net loss of $553,033 and a comprehensive loss of $593,754, reversing prior-year net income of $363,524 and comprehensive income of $330,221. Management attributed the decline primarily to reduced business development and marketing activity in its corporate management consulting segment, a deliberate move tied to the reallocation of resources toward RWA development.

DUH Finds Up to 2.7M German Cars Fitted With Fake Catalytic Converters

Berlin – September 10, 2026 -- German environmental group Deutsche Umwelthilfe (DUH) has accused auto parts retailers and workshop chains of selling substandard replacement catalytic converters that leave up to 2.7 million gasoline vehicles with insufficient exhaust cleaning.

Lab tests find near-zero precious metal coating in five new replacement converters

Laboratory analysis commissioned by DUH on five new aftermarket catalytic converters found precious metal content approaching zero in nearly all units tested, undermining the long-term effectiveness of exhaust cleaning. Citing data from Germany's Federal Highway Research Institute (BASt), DUH said the majority of the roughly 300,000 replacement catalytic converters sold annually in Germany are substandard, prompting its conservative estimate of up to 2.7 million affected gasoline vehicles.

Germany's Poultry Demand to Grow 50% by 2040, Study Warns on Import Reliance

Berlin – September 10, 2026 -- Germany's poultry meat market is set to expand by more than 50% in volume by 2040, driven by annual demand growth of 2.1 to 2.5 percent overall and up to 3.4 percent for chicken, according to the Roland Berger Poultry Study 2026 commissioned by the Central Association of the German Poultry Industry (ZDG).

Self-sufficiency could fall from 91% to as low as 73% without new investment

Germany's poultry self-sufficiency rate stands at 91 percent today but risks dropping to between 73 and 77 percent by 2040 if domestic production capacity does not expand, the study finds. The import surplus has already grown more than eightfold, from 55,000 tonnes in 2014 to 462,000 tonnes in 2025. Chicken accounts for 82 percent of poultry imports, and roughly 60 percent of chicken imports now consist of premium cuts such as breast meat.

GCCL Sponsors ABP 2026 to Expand Asia-Pacific Clinical Lab Services

Image
GCCL Sponsors ABP 2026 to Expand Asia-Pacific Clinical Lab Services

Yongin, South Korea – September 10, 2026 -- GCCL (Global Clinical Central Lab), a South Korea-based clinical trial sample analysis provider, served as a Platinum Sponsor at the Asia Bio Partnering Forum 2026 (ABP 2026) in Singapore, held from August 31 to September 2, as it pursued expansion of its assay development and sample analysis services across the Asia-Pacific region.

ABP 2026 drew 650 industry professionals and 2,500 one-on-one partnering meetings

The forum brought together approximately 650 pharmaceutical and biotechnology executives, investors and life sciences stakeholders, with roughly 2,500 one-on-one partnering meetings held over three days. GCCL used the event to hold discussions with drug developers, contract research organizations (CROs) and regional stakeholders from Korea, China, Japan, Singapore, Vietnam and Europe.

LX Pantos Completes Cross-Border Missile Logistics for Korea's MAH Program

Image
LX Pantos Completes Cross-Border Missile Logistics for Korea's MAH Program

Seoul – – September 10, 2026 -- LX Pantos has completed a cross-border defense logistics project transporting air-to-air missiles (AAM) from France to South Korea for the Marine Attack Helicopter (MAH) program run by the Republic of Korea Marine Corps under the Defense Acquisition Program Administration (DAPA).

The project was executed on behalf of Korea Aerospace Industries (KAI), with the missiles supplied by an unnamed European defense contractor.

Charter flight moved missiles from Châteauroux to Incheon as sole cargo

LX Pantos organized a dedicated charter flight from Châteauroux airport in France to Incheon International Airport, carrying the AAM as the only cargo aboard the aircraft to maximize security. The shipment was then transported by road to a Republic of Korea Marine Corps unit in Pohang.

Beta Bionics Faces Securities Fraud Suit Over iLet Pump Disclosures

Los Angeles – September 10, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The suit covers investors who purchased BBNX shares between July 30, 2025 and February 24, 2026, with a lead plaintiff filing deadline set for November 3, 2026.

Complaint alleges Beta Bionics downplayed FDA findings on its iLet insulin pump

The complaint centers on the iLet Bionic Pancreas insulin pump, Beta Bionics' sole commercialized product. After the company disclosed that the FDA had issued a Form 483 following a manufacturing facility inspection, defendants allegedly told investors the agency's observations were limited to complaint-reporting criteria and did not reflect underlying device problems.